ProBioGen and Marea Therapeutics Inc. have successfully completed a sprint project to deliver clinical material for MAR002.

A recently published study by the the Western Ontario Registry for Early OA (WOREO) Knee Study team suggests that while synovitis increases in OA, the exhaustion and dysfunction of immune-regulatory ...

ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs 05.03.2025 / 22:07 CET/CEST The issuer is solely responsible for the content of this ...

An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.

Symbiosis’ completion of the FDA regulatory review is expected to increase the company’s commercial-scale sterile manufacturing capabilities.

Enzene’s two facilities in Pune, India have received European Union (EU) GMP certification to provide commercial-scale ...

Micreos Pharmaceuticals AG (”Micreos”), a preclinical-stage biopharmaceutical company, specializing in developing Engineered ...

A global elderly and aging population has significant impacts, not only in terms of individual health risk but in terms of ...

By registering with CLIA, Avance Biosciences asserts that it has established the necessary infrastructure and quality systems to meet rigorous quality standards and federal regulatory requirements for ...

Objective Live biotherapeutic products (LBPs) are biological products composed of living micro-organisms, developed to ...